Navigation Links
Bare metal stents deliver gene therapy to heart vessels with less inflammation in animal studies

Improved materials may allow stents, tiny metal scaffolds inserted into blood vessels, to better deliver beneficial genes to patients with heart disease, by reducing the risk of inflammation that often negates initial benefits. The new technique, using a compound that binds in an extremely thin layer to bare metal surfaces, may have potential uses in other areas of medicine that make use of metallic implants.

Cardiologists frequently treat heart disease patients now by using stents to expand partially blocked blood vessels and improve blood flow. However, new obstructions may gradually form within the stents themselves and dangerously narrow the passageway. A newer generation of stents releases drugs to counteract this renarrowing process, called restenosis, but the polymer coatings that initially hold the drugs to the stents may stimulate inflammation. The inflammation in turn leads to restenosis.

Researchers at The Children's Hospital of Philadelphia have developed a novel technique to attach therapeutic genes to a stent's bare metal surface. This technique allows the genes to help heal the surrounding blood vessels, while avoiding the inflammation caused by polymer coatings.

The research team reported their proof-of-principle study, using cell culture and animal models, in the early edition of the Proceedings of the National Academy of Sciences, published online this week.

"This is the first study to demonstrate successful delivery of a gene vector from a bare metal surface," said senior author Robert J. Levy, M.D., the William J. Rashkind Chair of Pediatric Cardiology at The Children's Hospital of Philadelphia. A gene vector is a biological substance, in this case an adenovirus, capable of delivering a therapeutic gene to target cells.

Dr. Levy's team created a unique water-soluble compound, polyallylamine biphosphonate, that binds to the stent's metal alloy surface in a layer with the thickness of only a single molecule.
'"/>

Source:Children's Hospital of Philadelphia


Page: 1 2

Related biology news :

1. Defenseless plants arm themselves with metals
2. Encoded metallic nanowires reveal bioweapons
3. Particle size matters to bacteria ability to immobilize heavy metals
4. New methods of gene delivery using lasers
5. Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs
6. Self-assembled DNA buckyballs for drug delivery
7. New research could help us deliver genes for new bone formation
8. Cookbook recipes would cure disease with nontoxic DNA delivery systems
9. Discarded placentas deliver researchers promising cells similar to embryonic stem cells
10. Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates
11. Cellular scale drug delivery from the inside out

Post Your Comments:
(Date:11/25/2009)...e heart pumps some 250 million liters of blood thr... fibers of the heart have to be extremely durable....er, vice chair of the Department of Medicine III a...Dr. H. A. Katus), has discovered a protein that is...cular unit, the sarcomere. In cooperation with oth...
(Date:11/25/2009)... just as vital to your health as what you eat, fou...l Studies. Their experiments in mice revealed that... in the liverthe body,s metabolic clearinghouseis ...dy,s circadian clock as conventional wisdom had it... a large number of genes completely independent of...
(Date:11/24/2009)...) today named 12 new grant recipients for 2009. Th...ive work across a broad spectrum of lupus research... and potential to drive scientific discovery to ul...ase of systemic lupus. , The 2009 grants go to b...he nation and include interdisciplinary and highly...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Tyco International to Present at the Citi Industrial Manufacturing 26amp 3B Transportation Conference 60962 1Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 14768 1Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 14768 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 14768 3Pharma and Biotech Leaders to Converge in Shanghai 14765 1Pharma and Biotech Leaders to Converge in Shanghai 14765 2
...ow highlight research in the ESA journals Frontie...ological Applications and Ecological Monographs ... wildfire severity but may invite invasives , ...compares the effectiveness of fire fuel reduction ...ogate Study. Four articles examine the effects of ...
.... Prenatal exposure to an insecticide commonly us...ty epidemic in women, according to a new study inv...rs. , More than 250 mothers who live along and ea...xposure to DDE a breakdown of DDT. The study, pub...on of Occupational and Environmental Medicine , a...
...as a moon named Deimos, so it seems only appropria... have its own DEIMOS. This DEIMOS, however, is an ...vements of fish and zooplankton. , MARS, which st...sists of a node the size of two compact cars that ...rnet connection for scientific instruments. Connec...
Other Biology News:Highlights from the March editions of ESA journals 2Highlights from the March editions of ESA journals 3Exposure to insecticide may play role in obesity epidemic among some women 2DEIMOS joins MARS and its satellite of instruments on seafloor 2DEIMOS joins MARS and its satellite of instruments on seafloor 3
(Date:11/24/2009).../PRNewswire-FirstCall/--IES(Nasdaq: IESC ),aleadin...emsandservicesforthecommercial,industrialandreside...ssgrouphasbeenawardedacontractfromManhattanTorconJ...tylab(BSL-4)replacementfacilityattheU.S.ArmyMedica...FortDetrickinFrederick,Md. ,, ThenewUSAMRIIDrep...
(Date:11/24/2009)... The New York investment bank KTA Capital,s cli...d an AU$6.7 mil convertible note private placement...lacement was arranged by KTA Capital as Neuren,s e... New York (PRWEB) November 23, 2009 ...pital, LLC ("KTA Capital") has announced...
(Date:11/24/2009)...HEIM,Ontario,Nov.24/PRNewswire-FirstCall/--DowAgro...ofHylandSeeds,adivisionofThompsonsLimitedofBlenhei...dDowAgroSciences,currentseedsbusinessasthecompanya... andDowAgroSciencesHerbicideTolerantTraitTechnolo...enearfuture. ,, "Thisacquisitionbringstogethert...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--Sigma-AldrichCorporation(...enceonTuesday,December1stat1:45PMGMTinLondon,7:45A...dcastovertheInternetavailableat http://inve s t...bcast"icontoaccessthisfile. ,, AboutSigma-Ald...chnologycompany.Itschemicalandbiochemicalproductsa...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...e profiling of protein biomarkers in tissue now, ...utions through Brigham and Women,... 29 HistoRx, Inc., announced today,that the patho... (BWH) will,begin making the company,s AQUA(R) tec...to the more than 900 Dana-Farber/Harvard Cancer Ce...
...atic, or fully differentiated, human cells back to...any of the significant scientific and social chall...help realize the promise of regenerative medicine....monstrated that such a transformation (reprogrammi...nefficient and, when it does work, poorly understo...
..., Inc. (Nasdaq:,SQNM) today announced that a live ...will be provided for its analyst and investor brie...enatal Diagnostics." Details of the,event are as f...nvasive Prenatal Diagnostics, When: Tuesday, ... http://www.sequenom.com , Agenda: Hosted by:...
Other Biology Technology:HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center 2HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center 3New insights into cellular reprogramming revealed by genomic analysis 2Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3 2
QuantiChrom Zinc Assay Kit from BioAssay Systems
Mouse Anti-Human PDGF R beta Monoclonal Antibody, Unconjugated, Clone PR7212 from R&D Systems
Mouse IL-23, Unconjugated from R&D Systems
Rabbit Serum from Lifeblood Medical, Inc.
Biology Products: